Gene · 4821
NIH grants1,452
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 1,452
Download this page as JSON| Grant | Title | NKX2-2 papers | Newest fiscal year |
|---|---|---|---|
| R01DA044283 | Deep Sequencing, Phenotyping, and Imputation in Large-Scale Biobanks: A Novel and Cost-Effective Framework to Identify Rare Mutations Associated with Addiction | 1 | 2024 |
| R01DK048106 | Mechanism of action for the epithelial-specific ER stress sensor IRE1β in regulating intestinal homeostasis and host defense | 1 | 2024 |
| R01DK048280 | Proinsulin Trafficking for Insulin Biosynthesis | 1 | 2024 |
| R01DK111174 | Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion | 1 | 2024 |
| R01DK123329 | Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes | 1 | 2024 |
| R01DK126444 | iPLA2beta-mediated alternative splicing and beta-cell death in type 1 diabetes | 1 | 2024 |
| R01DK128932 | Genetic and physiologic regulation of pig islet development and function | 1 | 2024 |
| R01DK129464 | Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes | 1 | 2024 |
| R01EB015611 | Solar-Eclipse Computational Tools for Imaging Genetics | 1 | 2024 |
| R01HD100535 | Role of Slc25a32 and Its Interaction with Lrp6 in the Etiology of Neural Tube Defects | 1 | 2024 |
| R01HL059367 | Epidemiology of Venous Thrombosis and Pulmonary Embolism | 1 | 2024 |
| R01HL105756 | CHARGE consortium: omics discovery for CVD and aging phenotypes | 1 | 2024 |
| R01HL122358 | Progressive seizure-induced cardiorespiratory dysfunction in a novel mutant rat model of seizure disorder | 1 | 2024 |
| R01HL156947 | Transcriptomic Entropy to Quantify Maturation of PSC-Derived Cardiomyocytes | 1 | 2024 |
| R01MH110487 | Cellular and Molecular Analysis of the Psychiatric Risk Gene Transcription Factor 4 (TCF4) | 1 | 2024 |
| R01MH123619 | Genome-Wide Association Analysis of Suicide Death | 1 | 2024 |
| R01NS034939 | Targeting the Integrated Stress Response to Protect Oligodendrocyte lineage Cells | 1 | 2024 |
| R01NS067550 | ZFP24 Control of the myelination program of oligodendrocytes | 1 | 2024 |
| R01NS115867 | New sterol-binding targets and optimized EBP inhibitors for promoting remyelination | 1 | 2024 |
| R01NS116141 | Transcriptional Control of Motor Neuron Maturation | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4821/grants?page=15